1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,430 | 2,660 | 06.02. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | BPC INSTRUMENTS AB: BPC Instruments strengthens the BPC Go platform - launches new solution for advanced process data logging | 1 | Cision News | ||
| 16.12.25 | BPC Instruments AB: BPC Instruments partners with SixRing to provide quality assurance for the EU and UK biomethane markets | 519 | PR Newswire | LUND, Sweden, Dec. 16, 2025 /PRNewswire/ -- BPC Instruments AB (publ) has entered into a collaboration with SixRing, the Canadian technology company behind Stimulose, a new feedstock additive... ► Artikel lesen | |
| 20.11.25 | BPC INSTRUMENTS AB: BPC Instruments secures new order for several BPC Go units from an international energy group | 2 | Cision News | ||
| 20.11.25 | BPC Instruments AB: BPC Instruments secures new order for several BPC Go units from a international energy group | 518 | PR Newswire | LUND, Sweden, Nov. 20, 2025 /PRNewswire/ -- BPC Instruments AB (publ) has received a new order valued at approximately SEK 0.9 million for several BPC Go units from a major international... ► Artikel lesen | |
| 12.11.25 | BPC Instruments AB: BPC Instruments reports results for the period January - September 2025 | 803 | PR Newswire | LUND, Sweden, Nov. 12, 2025 /PRNewswire/ -- BPC Instruments AB (publ) hereby publishes the interim report for the period January 1 - September 30, 2025. The interim report is available... ► Artikel lesen | |
| 10.09.25 | BPC INSTRUMENTS AB: BPC Instruments launches consultation and training service to strengthen customer value | 1 | Cision News | ||
| 02.09.25 | BPC Instruments AB: BPC Instruments expands into the textile sector - receives order from a global materials company | 301 | PR Newswire | LUND, Sweden, Sept. 2, 2025 /PRNewswire/ -- BPC Instruments AB (publ) is extending the industrial application of its BPC® Blue platform into the textiles & apparel sector, broadening the... ► Artikel lesen | |
| BPC INSTRUMENTS Aktie jetzt für 0€ handeln | |||||
| 27.08.25 | BPC Instruments AB: BPC Instruments reports results for H1 and Q2 2025 | 494 | PR Newswire | LUND, Sweden, Aug. 27, 2025 /PRNewswire/ -- BPC Instruments (publ) hereby publishes the half-year report for the period January 1 - June 30, 2025. The half-year report is available as an... ► Artikel lesen | |
| 05.08.25 | BPC Instruments AB: BPC Instruments secures 4.4 MSEK order from a public research organisation in the Philippines | 389 | PR Newswire | LUND, Sweden, Aug. 5, 2025 /PRNewswire/ -- BPC Instruments AB (publ) has received an order valued at approximately SEK 4.4 million from a public research institution in the Philippines, operating... ► Artikel lesen | |
| 21.07.25 | BPC Instruments AB: BPC Instruments receives order from Cornell University of 1 MSEK | 318 | PR Newswire | LUND, Sweden, July 21, 2025
/PRNewswire/ -- BPC Instruments AB (publ) has received an order from Cornell University in the United States valued at approximately SEK 1 million. The order... ► Artikel lesen | |
| 04.06.25 | BPC Instruments AB: BPC Instruments receives orders from KU Leuven valued at 0.7 MSEK | 436 | PR Newswire | LUND, Sweden, June 4, 2025 /PRNewswire/ -- BPC Instruments AB (publ) ("BPC") announces orders from KU Leuven university in Belgium. The orders include the delivery of several instruments... ► Artikel lesen | |
| 07.05.25 | BPC Instruments AB: BPC Instruments Annual Report for 2024 | 979 | PR Newswire | LUND, Sweden, May 7, 2025 /PRNewswire/ -- BPC Instruments (publ) hereby publishes the Annual Report for the year 2024. The Annual Report is available as an attached file to this release and... ► Artikel lesen | |
| 07.05.25 | BPC Instruments AB: BPC Instruments reports results for Q1 2025 | 1.005 | PR Newswire | LUND, Sweden, May 7, 2025 /PRNewswire/ -- BPC Instruments (publ) hereby publishes the interim report for the period January 1 - March 31, 2025. The interim report is available as an attachment... ► Artikel lesen | |
| 26.02.25 | BPC Instruments AB: BPC Instruments reports result for year 2024 | 776 | PR Newswire | LUND, Sweden, Feb. 26, 2025 /PRNewswire/ -- BPC Instruments (publ) hereby publishes the year-end report for the year 2024. The year-end report is available as an attached file to this release... ► Artikel lesen | |
| 26.02.25 | BPC Instruments AB: BPC Instruments reports result for year 2024 | 620 | PR Newswire | LUND, Sweden, Feb. 26, 2025 /PRNewswire/ -- BPC Instruments (publ) hereby publishes the year-end report for the year 2024. The year-end report is available as... ► Artikel lesen | |
| 20.02.25 | BPC Instruments AB: BPC Instruments receives order from DairyExperts for animal nutrition research | 603 | PR Newswire | LUND, Sweden, Feb. 20, 2025 /PRNewswire/ -- BPC Instruments AB (publ) ("BPC") announces an order of approx. SEK 0.5 million from DairyExperts, a US-based organisation specialising in livestock... ► Artikel lesen |
16 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PRAXIS PRECISION MEDICINES | 319,57 | +4,56 % | Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| QIAGEN | 43,170 | -0,70 % | Qiagen übertrifft Markterwartungen im vierten Quartal | DJ Qiagen übertrifft Markterwartungen im vierten Quartal
DOW JONES--Qiagen hat im Schlussquartal 2025 den Umsatz gesteigert, der operative Gewinn ging gegenüber dem Vorjahr zurück. 2026 rechnet... ► Artikel lesen | |
| AVIDITY BIOSCIENCES | 72,90 | +0,11 % | Avidity Biosciences, Inc. - 8-K, Current Report | ||
| TARSUS PHARMACEUTICALS | 64,62 | +4,24 % | Tarsus Pharmaceuticals, Inc: Tarsus Reports Third Quarter 2025 Financial Results and Recent Business Achievements | Delivered quarterly XDEMVY® net sales of approximately $119 million, up approximately 147% year-over-year Weekly multi-patient prescribers grew approximately 30% in the third quarter underscoring... ► Artikel lesen | |
| SUMMIT THERAPEUTICS | 14,990 | +8,23 % | H.C. Wainwright reiterates Buy rating on Summit Therapeutics stock | ||
| ERASCA | 12,290 | +3,45 % | Erasca, Inc.: Erasca Announces Pricing of Upsized Public Offering of Common Stock | SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for... ► Artikel lesen | |
| RECURSION PHARMACEUTICALS | 3,960 | +11,24 % | Recursion Pharmaceuticals, Inc.: Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks | REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden and a 43% median reduction after 12 weeks of treatment (n=12)After 12 weeks... ► Artikel lesen | |
| APOGEE THERAPEUTICS | 62,19 | +0,10 % | Jefferies lowers Apogee Therapeutics stock price target on OX40 concerns | ||
| IMMUNOVANT | 27,040 | +12,39 % | Immunovant Inc.: Immunovant Provides Corporate Updates and Reports Financial Results for the Third Quarter Ended December 31, 2025 | IMVT-1402 potentially registrational trial in difficult-to-treat rheumatoid arthritis (D2T RA) fully enrolled, with topline data expected in the second half of calendar year 2026; topline data from... ► Artikel lesen | |
| STRUCTURE THERAPEUTICS | 74,96 | +2,39 % | Structure Therapeutics Inc.: Structure Therapeutics Announces Initiation of Phase 1 Clinical Study of Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity | SAN FRANCISCO, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for... ► Artikel lesen | |
| MINERALYS THERAPEUTICS | 29,770 | +5,53 % | Mineralys Therapeutics, Inc.: Mineralys Therapeutics' Phase 3 Launch-HTN Trial of Lorundrostat Recognized in Inaugural Journal of the American Medical Association (JAMA) "Research of the Year" Roundup | - Launch-HTN, the largest trial of an aldosterone synthase inhibitor conducted among participants with uncontrolled or treatment-resistant hypertension, was one of nine studies selected as most impactful... ► Artikel lesen | |
| LIMINATUS PHARMA | 1,840 | -10,24 % | Liminatus Pharma, Inc. - 8-K, Current Report | ||
| DAY ONE BIOPHARMACEUTICALS | 11,410 | +8,87 % | Day One Biopharmaceuticals, Inc.: Day One Announces Preliminary 2025 OJEMDA Net Product Revenue And Provides 2026 Net Product Revenue Guidance | Preliminary 2025 net product revenue of $155.4 million, representing 172% year-over-year growth; OJEMDA 2026 U.S. net product revenue projected to be $225 - $250 million Company to present on corporate... ► Artikel lesen | |
| AMYLYX PHARMACEUTICALS | 13,980 | +7,62 % | Gubra A/S: Amylyx Pharmaceuticals Announces Nomination of AMX0318 as a Novel, Long-Acting GLP-1 Receptor Antagonist Development Candidate, Identified in Collaboration with Gubra | AMX0318 selected as development candidate after meeting key criteria, demonstrating a robust chemical stability profile, strong in vitro potency, evidence of in vivo efficacy and tolerability, high... ► Artikel lesen | |
| OLEMA PHARMACEUTICALS | 25,360 | +1,40 % | Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
Das Unternehmen BPC INSTRUMENTS AB kann der Branche Biotechnologie zugeordnet werden. Der aktuelle Kurs liegt bei 2,430 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BPC INSTRUMENTS AB finden Sie auf Wallstreet Online.